Cdk2/Cyclin Inhibitory Peptide II

Modify Date: 2024-01-10 10:41:59

Cdk2/Cyclin Inhibitory Peptide II structure	Common Name	Cdk2/Cyclin Inhibitory Peptide II
	CAS Number	237392-85-7	Molecular Weight	2595.07
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₁₀H₂₀₀N₄₈O₂₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cdk2/Cyclin Inhibitory Peptide II

Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].

Name	Cdk2/Cyclin Inhibitory Peptide II

Description	Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> CDK
Target	CDK[1].
In Vitro	Cdk2/Cyclin Inhibitory Peptide II (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: U2OS osteosarcoma cells Concentration: 0-150 µM Incubation Time: 24 h Result: Exhibited good activity to kill U2OS osteosarcoma cells.

Molecular Formula	C₁₁₀H₂₀₀N₄₈O₂₅
Molecular Weight	2595.07